What is the recommended treatment for a patient with Group B strep (Streptococcus agalactiae) and a penicillin (PCN) allergy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Group B Streptococcus in Patients with Penicillin Allergy

For patients with Group B Streptococcus (GBS) infection and penicillin allergy, the recommended treatment depends on the severity of the allergy, with vancomycin being the first-line treatment for severe penicillin allergies when susceptibility testing is not available. 1

Assessment of Penicillin Allergy

  • Determine if the patient has a high risk for anaphylaxis (severe penicillin allergy), characterized by history of anaphylaxis, angioedema, respiratory distress, or urticaria following penicillin or cephalosporin administration 1, 2
  • Verification of reported penicillin allergy is important, as approximately 10% of persons with penicillin allergy have immediate hypersensitivity reactions to cephalosporins 2

Treatment Algorithm Based on Allergy Severity

For Non-Severe Penicillin Allergy:

  • Cefazolin is the recommended alternative (2g IV initial dose, then 1g IV every 8 hours until treatment completion) 1, 2
  • GBS isolates remain highly susceptible to cefazolin, with minimum inhibitory concentrations consistently low 2

For Severe Penicillin Allergy:

  • Obtain antimicrobial susceptibility testing for clindamycin and erythromycin if possible 1, 2
  • If the isolate is susceptible to clindamycin, administer clindamycin 900 mg IV every 8 hours 1, 2
  • If susceptibility testing is not available or the isolate is resistant to clindamycin, administer vancomycin 1g IV every 12 hours 1, 2

Antimicrobial Resistance Considerations

  • All GBS isolates remain susceptible to penicillin worldwide 1
  • Erythromycin resistance has been increasing in GBS strains, with studies showing resistance rates of 12% in some populations 3
  • Clindamycin resistance has also been reported, with rates of approximately 7% 3
  • The CDC advises against using erythromycin for GBS infections due to increasing resistance 1

Clinical Pearls and Pitfalls

  • Always obtain susceptibility testing when treating GBS infections in penicillin-allergic patients 1, 2
  • Consider consultation with an infectious disease specialist for complicated cases or when limited treatment options are available 1
  • Avoid cefazolin in patients with severe penicillin allergy due to risk of cross-reactivity 1
  • Reserve vancomycin for cases where no other options exist, due to concerns about promoting antimicrobial resistance 2
  • Antibiotic susceptibility testing should be performed on GBS isolates from penicillin-allergic patients, as this is an area for improvement in antibiotic stewardship 4

Special Considerations for Pregnant Patients

  • For pregnant women with GBS colonization and penicillin allergy requiring intrapartum prophylaxis, follow the same principles based on allergy severity 4
  • Cefazolin is most frequently used for non-severe allergies, followed by vancomycin and clindamycin for severe allergies 4
  • Intrapartum exposure to penicillin for GBS treatment does not increase the risk of penicillin allergy in children 5

References

Guideline

Treatment of Group B Strep UTI in Patients with Severe Penicillin Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Alternative Antibiotics for Group B Streptococcus (GBS) Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antibiotic Prescribing Practices in Group B Streptococcus Positive Obstetric Patients with Penicillin Allergy.

South Dakota medicine : the journal of the South Dakota State Medical Association, 2022

Research

Intrapartum antibiotic exposure for group B Streptococcus treatment did not increase penicillin allergy in children.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.